Eric Nestler

Eric Nestler. He is an American neuroscientist and psychiatrist renowned for his pioneering research into the molecular biology of addiction and mood disorders. His work has fundamentally advanced the understanding of how chronic exposure to drugs of abuse and stress induces long-lasting changes in gene expression within the brain's reward system. Serving as the Dean for Academic and Scientific Affairs and Director of the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai, he is a leading figure in translational research aimed at developing new treatments for psychiatric illness.

Early life and education

Born in New York City, he developed an early interest in science. He completed his undergraduate studies at Yale University, earning a Bachelor of Science degree. He then pursued a combined Doctor of Medicine and Doctor of Philosophy program at Stanford University, training in both psychiatry and neuroscience. His doctoral and early postdoctoral work focused on the neuropharmacology of neurotransmitter systems, laying the groundwork for his future investigations into neural plasticity.

Academic career and research

Following his training, he held faculty positions at Yale University and the University of Texas Southwestern Medical Center. In 2004, he joined the Icahn School of Medicine at Mount Sinai, where he established a major research program. His laboratory employs a multidisciplinary approach, integrating techniques from behavioral neuroscience, molecular genetics, and epigenetics. A central theme of his research is investigating the transcription factor ΔFosB and its role as a sustained molecular switch in the nucleus accumbens and other limbic system regions, driving persistent changes in behavior following drug exposure or chronic stress.

Major contributions to neuroscience

His most significant contributions involve elucidating the neuroadaptations that underlie drug addiction and depression. His team demonstrated that cocaine, opioids, and other substances cause enduring alterations in chromatin remodeling and gene expression within the mesolimbic pathway. This work established the concept of addiction as a form of maladaptive learning and memory. Parallel studies on animal models of depression, such as chronic social defeat stress, identified similar molecular mechanisms in the prefrontal cortex and hippocampus, revealing shared pathways between addiction and mood disorders and identifying potential targets for novel antidepressant therapies.

Awards and honors

His research has been recognized with numerous prestigious awards, including the Pasarow Award in Neuropsychiatry, the Falcon Award from the Brain & Behavior Research Foundation, and the Goldman-Rakic Prize for outstanding achievement in cognitive neuroscience. He is an elected member of the National Academy of Medicine and the American Academy of Arts and Sciences. In 2016, he received the Mika Salpeter Lifetime Achievement Award from the Society for Neuroscience, honoring his enduring impact on the field.

Selected publications

His influential body of work includes key papers such as "Transcriptional and epigenetic mechanisms of addiction" in *Nature Reviews Neuroscience*, "ΔFosB: a sustained molecular switch for addiction" in *Proceedings of the National Academy of Sciences*, and "Neurobiology of depression" in *Neuron*. He is also the author of the foundational textbook *Neurobiology of Mental Illness*, co-edited with Dennis Charney, Joseph Coyle, and Pamela Sklar, which is widely used in academic and clinical training.

Category:American neuroscientists Category:American psychiatrists Category:1954 births Category:Living people